Similar articles

• The patent ductus arteriosus.

  Friedman WF, Fitzpatrick KM, Merritt TA, Feldman BH. Friedman WF, et al. Clin Perinatol. 1978 Sep;5(2):411-36. Clin Perinatol. 1978. PMID: 371899 Review. No abstract available.
• Blockers of prostaglandin synthesis: a novel therapy in the management of the premature human infant with patent ductus arteriosus.

  Friedman WF, Printz MP, Kirkpatrick SE. Friedman WF, et al. Adv Prostaglandin Thromboxane Res. 1978;4:373-81. Adv Prostaglandin Thromboxane Res. 1978. PMID: 565580 No abstract available.
• When to treat the patent ductus arteriosus with indomethacin in very-low-birth-weight infants.

  Mahony L, Heymann MA, Carnero V, Brett C, Clyman RI. Mahony L, et al. Adv Prostaglandin Thromboxane Leukot Res. 1983;12:491-4. Adv Prostaglandin Thromboxane Leukot Res. 1983. PMID: 6221636 Clinical Trial. No abstract available.
• The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates: size matters.

  Tschuppert S, Doell C, Arlettaz-Mieth R, Baenziger O, Rousson V, Balmer C, Prêtre R, Dodge-Khatami A. Tschuppert S, et al. J Thorac Cardiovasc Surg. 2008 Jan;135(1):78-82. doi: 10.1016/j.jtcvs.2007.07.027. J Thorac Cardiovasc Surg. 2008. PMID: 18179922
• The relationship of symptomatic patent ductus arteriosus to respiratory distress in premature newborn infants.

  Cotton RB. Cotton RB. Clin Perinatol. 1987 Sep;14(3):621-33. Clin Perinatol. 1987. PMID: 3311542 Review.